Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-dir (Q40702192)
Jump to navigation
Jump to search
scientific article published on 20 April 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-dir |
scientific article published on 20 April 2016 |
Statements
1 reference
Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-dir (English)
1 reference
Yehuda Carmeli
1 reference
Jon Armstrong
1 reference
Peter J Laud
1 reference
Paul Newell
1 reference
Greg Stone
1 reference
Angela Wardman
1 reference
Leanne B Gasink
1 reference
20 April 2016
1 reference
1 reference
Identifiers
1 reference